Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-019805
Filing Date
2023-02-13
Accepted
2023-02-13 16:56:33
Documents
1
Group Members
FORESITE CAPITAL FUND V, L.P. ('FCF V')FORESITE CAPITAL MANAGEMENT IV, LLC ('FCM IV')FORESITE CAPITAL MANAGEMENT V, LLC ('FCM V')JAMES TANANBAUM ('TANANBAUM')

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236260d1_sc13ga.htm SC 13G/A 77064
  Complete submission text file 0001104659-23-019805.txt   78893
Mailing Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund IV, L.P. (Filed by) CIK: 0001704131 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000 31 (0)71 203 6410
Pharvaris N.V. (Subject) CIK: 0001830487 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92181 | Film No.: 23619494
SIC: 2834 Pharmaceutical Preparations